UN Commission on Narcotic Drugs Opens Its Discussion of Cannabis Rescheduling

Share This
Fourth Intersessional Meeting of its 62nd Session on June 24, 2019, in Vienna, Austria. Delegates spent most of their time discussing a report from the World Health Organization's 41st Expert Committee on Drug Dependence that recommends major changes in the international scheduling of cannabis and cannabinoids." data-share-imageurl="">

The UN's Commission on Narcotic Drugs held the Fourth Intersessional Meeting of its 62nd Session on June 24, 2019, in Vienna, Austria. Delegates spent most of their time discussing a report from the World Health Organization's 41st Expert Committee on Drug Dependence that recommends major changes in the international scheduling of cannabis and cannabinoids.

The ECDD's recommendations were reported to UN Secretary General in a letter from the Director General of the WHO, Dr. Tedros Adhanom Ghebreyesus, dated January 24, 2019.

Specifically in regard to cannabis and cannabis-related substances, the ECDD recommends:

Cannabis and cannabis resin
• To be deleted from Schedule IV of the Single Convention on Narcotic Drugs (1961)

Dronabinol (delta-9-tetrahydrocannabinol)
• To be added to Schedule I of the Single Convention on Narcotic Drugs (1961)
• To be deleted from Schedule II of the Convention on Psychotropic Substances (1971), subject to the CND's adoption of the recommendation to add dronabinol and its stereoisomers (delta-9-tetrahydrocannabinol) to Schedule I of the Single Convention on Narcotic Drugs (1961)

Tetrahydrocannabinol (Isomers of delta-9-tetrahydrocannabinol)
• To be added to Schedule I of the Single Convention on Narcotic Drugs (1961) subject to the CND's adoption of the recommendation to add dronabinol and its stereoisomers (delta-9-tetrahydrocannabinol) to Schedule I of the Single Convention on Narcotic Drugs (1961)
• To be deleted from Schedule I of the Convention on Psychotropic Substances (1971), subject to the CND's adoption of the recommendation to add tetrahydrocannabinol to Schedule I of the Single Convention on Narcotic Drugs (1961)

Extracts and tinctures
• To be deleted from Schedule I of the Single Convention on Narcotic Drugs (1961)

Cannabidiol preparations
• To give effect to the recommendation of the fortieth meeting of the ECDD that preparations considered to be pure cannabidiol (CBD) should not be scheduled within the International Drug Control Conventions by adding a footnote to the entry for cannabis and cannabis resin in Schedule I of the Single Convention on Narcotic Drugs (1961) to read "Preparations containing predominantly cannabidiol and not more than 0.2 percent of delta-9-tetrahydrocannabinol are not under international control"

Preparations produced either by chemical synthesis or as preparation of cannabis, that are compounded as pharmaceutical preparations with one or more other ingredients and in such a way that delta-9-tetrahydrocannabinol (dronabinol) cannot be recovered by readily available means or in a yield which would constitute a risk to public health
• To be added to Schedule III of the Single Convention on Narcotic Drugs (1961)

The meeting on June 24 represents the beginning of a process within the CND to consider the recommendations of the WHO's ECDD. Proceedings of the CND are webcast live but are not archived. DWF Editor Doug McVay records as much as possible of the live webcast, which he uses on his weekly radio public affairs program Century of Lies.

Share This
Fourth Intersessional Meeting of its 62nd Session on June 24, 2019, in Vienna, Austria. Delegates spent most of their time discussing a report from the World Health Organization's 41st Expert Committee on Drug Dependence that recommends major changes in the international scheduling of cannabis and cannabinoids." data-share-imageurl="">